Garcia, Julie
Daniels, Jay http://orcid.org/0000-0003-4022-6795
Lee, Yujin http://orcid.org/0000-0002-8419-8565
Zhu, Iowis http://orcid.org/0000-0001-7852-0987
Cheng, Kathleen
Liu, Qing
Goodman, Daniel http://orcid.org/0000-0003-3759-6883
Burnett, Cassandra
Law, Calvin http://orcid.org/0000-0002-6784-0085
Thienpont, Chloƫ http://orcid.org/0009-0005-2263-1422
Alavi, Josef
Azimi, Camillia http://orcid.org/0000-0003-0406-5840
Montgomery, Garrett http://orcid.org/0000-0002-8300-5071
Roybal, Kole T. http://orcid.org/0000-0003-3030-7954
Choi, Jaehyuk http://orcid.org/0000-0003-2379-2226
Article History
Received: 20 September 2022
Accepted: 2 January 2024
First Online: 7 February 2024
Competing interests
: K.T.R. is a co-founder, consultant, SAB member and stockholder of Arsenal Biosciences and Dispatch Therapeutics. He was a founding scientist and consultant and stockholder in Cell Design Labs, now a Gilead Company. K.T.R. holds stock in Gilead. K.T.R. is an exclusive adviser to Venrock. J.G. and J.D. are founding scientists and stockholders of Moonlight Bio. K.T.R. and J.C. are co-founders and stockholders of Moonlight Bio. K.T.R., J.C., J.G., J.D. and I.Z. are inventors on a University of California, San Francisco and Northwestern University provisional patent for enhancing adoptive T cell therapeutics; 63/412,300.